Re: [Langcom] Content in Lese

Amir E. Aharoni Wed, 02 Oct 2019 01:28:22 -0700

The very short answer is that it can be on Incubator or Multilingual
Wikisource.


I'm not sure whether it qualifies as a Wikipedia article, a news post, or a
translation of an academic article. If it's the latter, then it can be on
the Multilingual Wikisource. If it's a Wikipedia article or a news post,
then someone can make a Wikinews or Wikipedia Incubator and post it there.
I can help doing it.

In principle I have no problem at all if for a while it will remain the
only thing in this language posted on Wikimedia projects. However, I have
to note that I'm not sure how useful will it be in practice. Wikinews sites
are not so popular in general, and even less so in the Incubator. A
Wikipedia article in the Incubator is also hard to discover given the
current technology; that's why I've been trying to promote
https://phabricator.wikimedia.org/T228745 .

The best long-term outcome is that the person who wrote this translation
writes more useful articles that can be posted on a Wikipedia or Wikibooks
Incubator. (Wikibooks is an underappreciated project, but it could be
useful for small languages where a full-blown encyclopedia can be overkill.)

(Also, if the original English article [1] is in the public domain (and as
far as I can see, it is), then it can also be posted, probably on the
English Wikisource.)

[1]
https://www.nih.gov/news-events/news-releases/independent-monitoring-board-recommends-early-termination-ebola-therapeutics-trial-drc-because-favorable-results-two-four-candidates

--
Amir Elisha Aharoni · אָמִיר אֱלִישָׁע אַהֲרוֹנִי
http://aharoni.wordpress.com
‪“We're living in pieces,
I want to live in peace.” – T. Moore‬


‫בתאריך יום ד׳, 2 באוק׳ 2019 ב-3:43 מאת ‪James Heilman‬‏ <‪[email protected]
‬‏>:‬

> Hey All
>
> We have some content in Lese under an open license on Ebola. It is a
> translation of this
> https://www.nih.gov/news-events/news-releases/independent-monitoring-board-recommends-early-termination-ebola-therapeutics-trial-drc-because-favorable-results-two-four-candidates
>
>
> Anywere it could live in the Wikipedia world?
>
> --
> James Heilman
> MD, CCFP-EM, Wikipedian
>
> Àngúdzù nà Óongɨ̀nɨ́ tòdhú nà àkɨsodzà ɨhdengu ba ùdhú òya
> dhu adhì àtona  ladze ladze nà òbénɨ ayi àsɨ̀lebhɨ òndè nà
> Èbhòlà bhayi iìwé RDC  adhì bho, àkisubà londɨ nà ɨlèmba ayi
> àmʉdó nà èdzo adhì bho bà édzɨ́tò adhì kèke bànɨ́.
>
>
>
> Oòngó òyɨ mʉ̀bhʉ́ bha 12 ánɨ̀ uùlénɨ̀ òyɨ bha 09 2019, àkokpè
> àmʉ̀dó nà òndè ánɨ̀ adhi àbhé 681 ɨlèbhɨ́ dhu bhàbè bànɨ́
> àmʉ̀dó kadza 725. Òndè nà Èbòlà lùsí badhì nà édzɨ́tò adhì
> kèke bà akòkpè àmʉ̀dó nà òndè ánɨ̀ adhì àbhé:  Ìbhógú na
> Katwa bà, Butembo bà àba Mangina bà. Ʉmbá lùsí bà nà ledhì
> ayɨ̀kasʉ́ nà sòkú nà kàlʉ̀ ayi nà àsɨ̀tagà « Institut national de
> recherche biomédicale » (INRB), àba àngúdzù ngbówú nà ʉ̀mbá lùsí
> bhayi nà ìbhórú ànda nà RDC ayi, àba ùdhu òya nà ʉ̀mbá lùsí
> bhadhì dhèkú èdzɨnà, àtagà ɨ̀dhé : Oòngɨ̀nɨ́ nà ùdhú òya dhú
> àyi nà ìbhógú nbgówú ɨ̀nɨ́ kèke ayi, tòdhó lʉ́bhó ánɨ̀
> (Alliance pour action medicale international, (ALIMA) àba, International
> Medical Corps (IMC), àba óbhó ʉ̀mbá lùsí tòdhú nà áwé èmbi ayi,
> tòdhó lʉ́bhó ánɨ̀ Médecin sans frontière, MSF), ùdhu òya ndɨ̀kà nà
> àsɨ̀taga : Edhi àmba nɨ òdhò ɨ̀dhó dhu,(ensemble pour sauver la vie)
> kadza lebhɨ lebhɨ nà àkɨsɨtayi àba àkɨsendà ɨ́ngámá ayi, ámʉ̀dó
> nà èlu ènda ndɨ́le ánɨ̀ àkɨsodzà kàlʉ̀ adhì, ɨ̀dhe àtagà (ZMapp,
> àba remdesivir, àba mAb114 àba RGEN-EB3), ɨ̀dhe àkɨbhà àmʉ̀dó nà
> àkɨsubà òndè nà Èbhòlà bhayi adhì ʉ̀mbá lùsí dhu. Táyí táyí
> ndɨ̀le kúkànɨ́ òyɨ mʉ̀dhʉ́ bha 20 tìmbá bha àmbʉ̀dzɨ́ ídzù èdhi
> ánɨ̀ 2018 ìbhógú ngbúwú nà Congo kèke bà (RDC) oòto adzɨbà bhé
> ayiwè òbénɨ òndè nà Ebola bha mʉ̀sʉ̀fʉ̀ àmʉ̀dó ibhèli ìbhógú
> ànda légò nà Nord-Kivu àba Ituri kèke bà ayi.
>
>
>
> Lebhɨ lebhɨ nà leyi àngúdzù nà àsɨ̀tʉnvʉ èlú ɨ̀nɨ́ nà àkisubà
> táyí táyí kèke bà ayi àdhì àba tʉ̀nvʉ tòdhú ɨ̀nɨ́ nà àsùyà
> ùdhú àmʉ̀dó dhèkú èmbi bà adhì nà àsʉ̀dza aàdúnɨ̀ òyɨ édhí
> édhi èlu ndɨ̀le lòndɨ dhú adhì ɨ̀nɨ́ àwʉ̀dza oòto. Londɨ nà
> ɨ́ngamá ùdhú kàkɨ dhú ayi èdɨ dhú adzɨtayí ɨ̀nɨ́ nà ùdhú ndɨ̀le
> àkɨsukà adhì nɨ́. Lebhɨ lebhɨ nà òyɨ mʉ̀bhʉ́ bha 09 tìmbá bha
> gbàndà ánɨ̀ 2019 ánɨ̀ ayi nɨ́ lɨvʉ, DSMB kɨtòna àkamòbhò táyí
> táyí àba àkamòkpè bhàbè òndè tòdhú nà àselè lɨvʉ adhì
> REGN-EB3 ɨ̀ngó dhu àba mAb114 áwé nà àsɨkasɨlòndɨ̀ táyí táyí
> kɨsalenɨ̀ ayi. Lonndɨ nà leyi kadza lèdzɨ́nɨ́ táyí táyí ná REGN-EB3
> kɨsoyà ayi kɨsɨlafù àmʉ̀dó nà àsɨ̀londɨ̀ àkòbhò táyí táyí
> adhì ʉ̀webhʉ ɨ́ngámá ayi nɨ́bà. Àkɨsubà àmʉ̀dó nà 499 adhì nà
> àkɨselè táyí táyí bà adhì bho bà adhì àkɨtàdhʉ́ àsíyènà
> àmʉ̀dó nà àkɨsubà REGN-EB3 àba mAb114 adhì àkadza sásè nà
> Oòdhò bhayi ánɨ̀ kàkʉ ɨlàdhí àmʉ̀dó dhèkú bhówá nà àkɨselè
> édzó ledhì kèke ádhi.
>
>
>
> Táyí táyí tòdhú nà itù àdhì, àba àsedɨ mòbhì ɨ̀nɨ́ adhì
> àkɨtalu  londɨ nà ùdhú kàkɨ ɨ́ngámá dhu leyi, àba ayɨ̀kásʉ́ ɨ̀nɨ́
> nà d’ ATC àdhi ɨtòsónɨbà dzù adhì nɨ́ àkɨtènɨ̀ òbhénɨ. Aba
> iìwé dzù nɨ́ òndè tòdhú nà mòbhɨ̀ ɨ̀dhe bhayi kɨ́sɨ́ngendanɨ̀
> adhì, òndè tòdhú nà lɨvʉ adhì nà REGN-EB3 àba  mAb114  adhì, àba
> òndè tòdhú ɨ̀nɨ́ nà àkɨsoga màlɨ́ bhadzɨ adhì òyɨ àmbʉ̀dzɨ́
> àkubà sásè nà òdhò bhayi mòkpè nà ʉ̀mbá lùsí tòdhú nà ɨ̀dhe
> bha kàlʉ̀ ayi bho bà, dò ɨ̀dhe kùbà REGN-EB3 àba mAb114.
>
>
>
> Tàyɨ táyí táyí nà áwé mba ayi mʉ̀tadhʉ̀ àsíyè bhètì áwé
> èdhi èlú ɨ̀nɨ́ nà àkɨsubà adhì nà àsɨtòdhù (áwé nà tìmbá
> bha ɨ̀sɨ́ bhayi mba bà sókó ùkà ùkà nà tìmbá bha àmbʉ̀dzɨ́ bhayi
> nà 2019, DSMB àba táyí táyí àbayìdhu ɨ̀nɨ́ kɨlèbhɨ àsíyènà
> londɨ nà itù adhì nà àkisubà adhì nà kɨsodzà àdhi kadza kàkʉ̀
> londɨ lùsí bhayi ùdhú kàkɨ ɨngámá dhu àba àkisubà táyí táyí
> kè bà ayi nɨ́ kásʉ́ èdɨ dhú.Londɨ àsubà táyí táyí kèke bà ayi
> nà kɨsodzà kòpèle ayi àwʉ̀kpe dò àyibhà bhúkù ɨ̀nɨ́ nà
> àkɨsokpè ʉ̀mbá lùsí dzù adhì kèke, mʉ̀sɨ̀letè tàyalɨ̀ àbha.
>
>
>
> Táyí táyí nà ndɨ̀le àkɨlèbhɨ àba l’INRB kedɨ̀ ògákékí kásʉ́
> ndɨ̀le kàkɨ dhú, àba sòkú ngbówú nà àsɨ̀tagá : Institut national
> des maladies allergiques et infectieuses (NIAID) adhì sòkú ngbówú
> ɨ̀nɨ́ nà ʉ̀mbá lùsí dzù adhì nà Etats-Unis adhì ánɨ̀. Àsʉ̀ngɨ́nɨ̀
> ùdhú nà èdhi ayi òya dhú adhì nà ìbhógú ànda ngbówú ɨ̀nɨ́
> kèke adhì nà àsʉ̀tò ùdhú ʉ̀mbá lùsí bhayi àhdi nà àsɨ̀taga OMS
> leyi koyà ɨ́lé, àba ùdhu òya ngbówú  ɨ̀nɨ́ nà èdzɨto adhì nà
> lònzɨ̀ làga tòdhú ɨ̀nɨ́ bhadhì nà àsɨ̀tagà (MappBio, Gilead,
> Regeneron àba Ridgeback Biotherapeutics) ledhì kedɨ̀ ògákekí ɨ̀le
> dhú.
>
> NIAID, INRB àba OMS àalì lèdzɨ́nɨ́ kàkʉ̀ àmʉ̀dó nà ɨ́yá nà
> àsùyà kásʉ́ èlú awe nà ɨ́kókʉ́ ayi kèke bà táyí táyí nà layi
> dhù ádhi, àba àmʉ̀dó nà DSMB kèke adhì, àba òndè tòdhú ɨ̀nɨ́
> nà àkɨsoyà kásʉ́ táyí táyí nà layi kèke adhì awì nà ɨ̀dhe
> bhadhì ánɨ̀ bhàyɨ̀. Táyí táyí kéwʉ́ ngbówú nà lèdzɨ leyi nɨ́bà
> àba òbénɨ̀ ùdhu òya nà àmʉ̀ bhayi nɨ́bà àmʉ̀ katè úubà àdzɨdzɨ
> bà bhé àmʉ̀ katè òbénɨ àba bhàdumbì ndéngé nà lonzɨ eèdɨ bhayi
> àba ɨɨ̀sɨ́ ɨ̀dhe òndè nà Èbhòlà bhayi ánɨ̀ ɨlabhʉ́nʉ̀ bhayi kèke
> kásʉ́ nà.
>
>
>
> ÀDHÈ :
>
> Tòdhó àsɨ̀lodhɨ̀ adhì nà : Anthony S. Fauci, Dìlèkìtélè nà
> NIAID : Dìlèkìtélè ngbówú nà INRB bhayi, ayɨ̀tàdhʉ ngbówú nà
> Jean-Jacques Muyembe-Tamfum, MD, Ph.D ; àba Michael J. Ryan MD,
> Dìlèkìtélè adzòyà plògàlámè bhayi nà OMS bhayi, bhètì òbénɨ
> ayi tóná nà ʉ̀mbá lùsí dhu.
>
>
>
> Aàdúnɨ̀
>
> Mʉ̀sedɨ̀ plògàlámè nà ɨ́tòdhónɨ̀ bhayi ayi, àdhu
>
> NIAID Àyɨ́ ngbówú nà àsɨtodho àba àsʉ̀ngɨ́nɨ̀ ayɨ̀kásʉ́ ɨ̀nɨ́ nà
> gùvèlènèma kèke adhì ánɨ̀ ayi:  (Dr. Fauci)
>
> (301) 402-1663
>
> [email protected]
>
> Mʉ̀sedɨ̀ plògàlámè nà ɨ́tòdhónɨ̀ bhayi ayi, àdhu
>
> Dr. Sabue Mulangu (Dr. Muyembe)
>
> +243 826 792 353
>
> [email protected]
>
> Mʉ̀sedɨ̀ plògàlámè nà ɨ́tòdhónɨ̀ bhayi ayi, àdhu
>
> Nyka Alexander (Dr. Ryan)
>
> +4179 634 0295
>
> [email protected]
>
>
>
> Mòkpè nà layi àkengbe áwé nà lɨvʉ ayi ánɨ̀ òyɨ mʉ̀bhʉ́ bha 12
> tìmbá bha gbàndà ánɨ̀ 2019 bha.
>
>
>
> US National Institute of Health, August 12, 2019.  Distributed with
> permission.
>
> Translated into Lese by Corneille Melimunvu for Athinkra, LLC.
> _______________________________________________
> Langcom mailing list
> [email protected]
> https://lists.wikimedia.org/mailman/listinfo/langcom
>

_______________________________________________
Langcom mailing list
[email protected]
https://lists.wikimedia.org/mailman/listinfo/langcom

Re: [Langcom] Content in Lese

Reply via email to